Core Insights - Infini Capital Management Ltd has fully exited its position in Baidu, selling 33,399 shares for an estimated transaction value of $4.40 million, reflecting a complete liquidation of its stake [2][7]. Company Overview - Baidu, Inc. is a leading provider of internet-based services in China, offering a diversified portfolio that includes online marketing, cloud computing, and digital media [6]. - The company utilizes artificial intelligence and proprietary platforms to enhance user engagement and monetization, focusing on both enterprise solutions and consumer entertainment [6]. - As of February 12, 2026, Baidu's market capitalization was $46.93 billion, with a revenue of $18.15 billion and a net income of $1.23 billion [4]. Financial Performance - Baidu shares were priced at $138.38, reflecting a 48.3% increase over the past year, significantly outperforming the S&P 500 by 35.35 percentage points [8]. - The company faced challenges, including an impairment charge of $2.2 billion and a nearly $1.6 billion loss during the quarter, alongside an 18% drop in advertising revenue in Q3 2025 [10]. Investor Sentiment - Infini Capital's decision to sell its Baidu holdings may indicate frustration with the stock's performance, as it has traded within a limited range since a significant sell-off in 2021 [11]. - The fund had been gradually reducing its Baidu position throughout 2025, ultimately closing it out in Q4 [11][12].

Fastly advances after record results and stronger guidance highlighted its growing role in supporting AI-related traffic across cloud infrastructure.NASDAQ : FSLYFastlyToday's Change( 13.87 %) $ 2.23Current Price$ 18.27Key Data PointsMarket Cap$2.4BDay's Range$ 16.06 - $ 19.1452wk Range$ 4.65 - $ 19.14Volume1.6MAvg Vol6MGross Margin54.40 %Fastly (FSLY +13.87%), an edge cloud platform for secure, scalable digital content delivery, closed Friday at $18.26, up 13.84%. The stock is advancing as investors react ...

Core Insights - DraftKings reported Q4 earnings with a 43% increase in sales and a more than threefold rise in adjusted EBITDA, but earnings fell short of Wall Street expectations, leading to a decline in stock price [5] - The company's conservative guidance for only 11% sales growth in 2026 disappointed investors, contributing to a significant drop in stock value [5] - DraftKings is currently trading at 2 times sales and 21 times free cash flow, reflecting a 53% decline in shares over the past year, indicating that its growth potential is reasonably priced [5] Company Performance - DraftKings' stock closed at $21.76, down 13.51%, with a market cap of $13 billion and trading volume reaching 65.6 million shares, significantly above its three-month average of 13.9 million shares [2] - The stock's 52-week range is between $21.02 and $53.61, highlighting the volatility and recent downturn in its market performance [2] Industry Context - The S&P 500 inched up 0.03% while the Nasdaq Composite slipped 0.22%, indicating mixed market performance on the day [3] - Other digital sports entertainment and gaming peers, such as Penn Entertainment, also experienced declines, with a 5.24% drop to $11.76 [3] Strategic Focus - DraftKings is shifting its focus towards improving margins and reducing stock-based compensation, which could enhance its stock performance if shareholder dilution is minimized [6] - The company is expanding into prediction markets, iGaming, fantasy sports, and lottery offerings, presenting a compelling investment thesis for those interested in the growing sports betting industry [6]

Company Overview - TTM Technologies is a leading global supplier of advanced printed circuit boards (PCBs) and RF components, focusing on high-complexity and mission-critical applications [6] - The company leverages scale, engineering expertise, and a diversified product mix to meet demanding customer requirements in technology-driven industries [6] - TTM Technologies serves various sectors, including aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation [8] Financial Performance - As of February 12, 2026, TTM Technologies had a market capitalization of $9.56 billion and revenue of $2.91 billion for the trailing twelve months (TTM) [4] - The company reported a net income of $177.45 million for the TTM [4] - In the fourth quarter, net sales increased by 19% year-over-year to $774.3 million, with non-GAAP EPS reaching a record $0.70 [7] - Full-year 2025 revenue was $2.9 billion, up 19%, while non-GAAP net income rose to $259.0 million, or $2.46 per diluted share [9] Recent Developments - On February 13, 2026, Neo Ivy Capital Management disclosed a new position in TTM Technologies, acquiring 100,879 shares valued at approximately $6.96 million [2] - TTM Technologies shares were priced at $92.33, reflecting a significant increase of 259.82% over the prior year, outperforming the S&P 500 by 246.92 percentage points [7] - The company's adjusted EBITDA margin expanded to 16.3% [9] Market Position and Strategy - TTM Technologies offers a comprehensive portfolio that includes high-density interconnect PCBs, flexible and rigid-flex PCBs, IC substrates, and advanced ceramic RF components [8] - The company generates revenue primarily through the manufacture and sale of advanced PCB and RF products, as well as system integration and custom assembly solutions [8] - Data Center Computing and Networking revenue accounted for 36% of total sales, driven by demand for generative AI [9]

Cohu's Q4 report arrived with a surprise that's causing investors to sell the stock.Cohu (COHU 6.89%) stock is losing ground in Friday's daily trading session. The tech company's share price was down 7.2% as of 3:20 p.m. ET amid roughly flat trading for the S&P 500 and the Nasdaq Composite. Cohu reported its fourth-quarter results after the market closed yesterday and delivered sales in line with Wall Street's expectations. On the other hand, the business reported a loss that was far larger than anticipated ...

Core Insights - Neo Ivy Capital Management has initiated a new position in American Healthcare REIT by purchasing 136,925 shares valued at approximately $6.44 million [2][8] - American Healthcare REIT has demonstrated strong financial performance, with a 16.4% same-store NOI growth in the third quarter, driven by significant increases in senior housing and integrated senior health campuses [7][10] - The company's stock price has increased by 93.3% over the past year, outperforming the S&P 500 with a one-year alpha of 80.37 percentage points [8] Company Overview - American Healthcare REIT operates a diversified portfolio of healthcare properties, including medical office buildings, senior housing communities, and skilled nursing facilities across the U.S. and U.K. [6][9] - The company has a market capitalization of $9.65 billion and reported a revenue of $2.20 billion for the trailing twelve months [4] - The dividend yield stands at 1.92%, indicating a return to shareholders [4] Financial Performance - GAAP net income attributable to controlling interest was reported at $55.9 million, equating to $0.33 per diluted share, while normalized FFO was $0.44 per share [10] - Management has raised full-year NFFO guidance to a range of $1.69 to $1.72, with expectations for same-store NOI growth reaching as high as 15% [10] Investment Implications - The new position by Neo Ivy Capital Management represents 1.02% of its reportable assets, indicating a strategic allocation to tap into healthcare real estate momentum [8][11] - The investment thesis for long-term investors is based on sustained occupancy rates above 90% in senior housing and disciplined capital allocation [11]

Company Overview - Garmin is a diversified company involved in various sectors including aviation services, marine electronics, automotive equipment, and wearables, not just fitness and GPS [2] - The company reported record revenue of $6.3 billion for fiscal year 2024, marking a 20% increase, with all five business segments achieving all-time highs [3] Financial Performance - Operating income for Garmin surged 46% to $1.59 billion, indicating strong financial health [3] - In Q3 2025, the fitness segment revenue increased by 30%, while the outdoor segment generated $498 million, despite a 5% decline due to previous year's product launches [4] - Garmin raised its revenue guidance for the full year to $7.1 billion, reflecting robust growth across its segments [4] Upcoming Earnings Report - Wall Street anticipates Garmin to report Q4 2025 earnings of $2.39 per share on revenue of approximately $2.01 billion, representing a 10.4% year-over-year increase [6] - The stock is currently trading around $205, significantly below its 52-week high of $261.69, and has a market cap of $39 billion [7] Investment Considerations - The price-to-earnings ratio stands at 23, with earnings growth projected at 11%, suggesting a fair valuation for consistent growth [9] - Caution is advised when buying stocks before earnings reports, as seen in October when Garmin's stock dropped 11.5% after missing revenue estimates by a small margin [8] - A strategy of partial investment now, with additional purchases if the stock dips post-report, is recommended for long-term investors [10][11]

Company Overview - Walker & Dunlop is a leading provider of commercial real estate finance solutions, focusing on multifamily and specialty housing markets [6] - The company offers a diverse portfolio of financing products, including first mortgage, construction, mezzanine, and bridge loans, as well as property sales brokerage and asset management services [9] - As of February 12, 2026, the company's stock price was $61.37, with a revenue of $1.24 billion and a net income of $114.99 million [4] Recent Developments - On February 13, 2026, First Sabrepoint Capital Management disclosed the sale of 90,000 shares of Walker & Dunlop for an estimated $6.39 million, reducing its stake to 30,000 shares valued at $1.80 million [2][8] - This sale decreased the fund's stake in Walker & Dunlop from 3.18% to 0.70% of its 13F assets under management (AUM) [8][10] Financial Performance - Walker & Dunlop's third-quarter transaction volume increased by 34% year over year to $15.5 billion, with revenue rising 16% to $337.7 million and diluted EPS increasing 15% to $0.98 [11] - The servicing portfolio reached $139.3 billion, up 4% from the previous year, and year-to-date transaction volume is running 38% higher than in 2024 [11] Market Position - Despite operational strength, shares of Walker & Dunlop have declined approximately 30% over the past year, underperforming the S&P 500 by 42.98 percentage points [8][12] - The company serves real estate owners and developers across the United States, with a focus on multifamily, affordable, senior, and student housing markets [9]

Core Insights - 2026 is anticipated to be a significant year for CRISPR Therapeutics, with potential growth opportunities in the biotech sector [1][2] Company Overview - CRISPR Therapeutics is a leader in gene editing, utilizing a CRISPR-based technique to treat diseases by modifying specific genes [4] - The company has achieved regulatory approval for its first CRISPR-based product, Casgevy, which treats blood disorders such as sickle cell disease and beta thalassemia [5] Revenue Potential - The launch of Casgevy is gaining momentum, with the product having "multi-billion-dollar potential," despite the company sharing profits with partner Vertex Pharmaceuticals [6] - The gene editing treatment process is lengthy, which may delay revenue generation, but the long-term prospects are promising [6] Upcoming Catalysts - In 2026, CRISPR Therapeutics plans to release clinical trial updates for several candidates, including CTX310 and CTX611, as well as initiate trials for new candidates targeting refractory hypertension and alpha-1 antitrypsin deficiency [8] - These updates and milestones could positively impact the stock in the near term and contribute to long-term success [9]

Company Overview - Kaiser Aluminum is a leading supplier of specialty aluminum products, serving high-value end markets such as aerospace, automotive, and packaging [6] - The company has a robust integrated manufacturing and distribution network, which supports a resilient business model focused on engineered applications and customer-specific solutions [6] - Kaiser Aluminum's revenue for the trailing twelve months (TTM) is $3.21 billion, with a net income of $91.40 million and a dividend yield of 2.23% [4] Recent Developments - On February 13, 2026, Brightline Capital Management, LLC disclosed a new position in Kaiser Aluminum, acquiring 168,000 shares valued at approximately $19.30 million [2][7] - This acquisition represents 7.8% of Brightline's reportable U.S. equity assets under management as of December 31, 2025 [7] - As of February 12, 2026, Kaiser Aluminum's stock price was $140.07, reflecting a 102.1% increase over the past year, significantly outperforming the S&P 500 by 89.2 percentage points [7] Financial Performance - Kaiser Aluminum's third-quarter results indicated net sales of $844 million and operating income of $49 million, with adjusted EBITDA reaching $81 million and a margin of 23.2% [9] - Management has raised its full-year 2025 adjusted EBITDA outlook to a 20% to 25% increase year over year, indicating strong operational momentum [9] - Despite a dip in shipments, profitability has expanded due to favorable pricing and metal dynamics, suggesting potential for continued earnings power [10]